Over 70 cats, 3 dogs rescued from ‘biohazard' hoarding conditions in Ohio
72 cats and three dogs were seized from a person accused of hoarding them in two 'biohazard' houses in Ohio, according to our CBS affiliate WOIO-19 TV.
[DOWNLOAD: Free WHIO-TV News app for alerts as news breaks]
TRENDING STORIES:
Local man arrested on child molestation warrant after 'intensive investigation'
Robocaller behind millions of illegal calls in Ohio permanently banned, attorney general announces
Man with filet knife arrested after standoff in Mercer County
The complaint reported that several cats were living in inhumane conditions in an Ashtabula house.
On May 15, an ACAPL officer and an Astabula dog warden responded to the house and found biohazardous conditions, according to a social media post from the league.
'With urine soaked floors, and a flea infestation and the majority of the cats requiring urgent veterinary care it was decided to remove the animals,' the post said.
Over 40 cats were rescued from the house.
The ACAPL told WOIO-19 that many of the cats were suffering from an upper respiratory infection from the fecal matter and ammonia odor.
Some of the cats were blind or only had one healthy eye, ACAPL said.
Two of the cats had to get surgery to remove their entire eyeballs and optic nerve, WOIO-19 reported.
While investigating the animal hoarding, authorities found a second location this week where the same person kept pets in unsanitary conditions.
28 cats and three dogs were rescued from this location.
The league reported the property to the health department because conditions were 'uninhabitable for both animals and humans.'
The ACAPL told WOIO-19 that these cats were in better health than those rescued from the first property.
Some have already been treated and cleared for adoption, the league added.
The conditions of the rescued dogs were not immediately available.
'This case has led to an overwhelming number of cats now in our care,' the league said on social media.
WOIO-19 reported that the league must take all strays and animals seized by the warden due to a contract with the county.
On May 20, the league posted to social media asking other rescues and shelters to help out and accept transfers.
According to WOIO-19, most of the cats and kittens rescued in this investigation can't be adopted yet due to age or health.
[SIGN UP: WHIO-TV Daily Headlines Newsletter]
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Insider
an hour ago
- Business Insider
Moderna announces FDA approved mNEXSPIKE, new vaccine against COVID-19
Moderna (MRNA) announced that the U.S. Food and Drug Administration, FDA, has approved mNEXSPIKE, a new vaccine against COVID-19, for use in all adults 65 and older, as well as individuals aged 12-64 years with at least one or more underlying risk factor as defined by the Centers for Disease Control and Prevention. 'The FDA approval of our third product, mNEXSPIKE, adds an important new tool to help protect people at high risk of severe disease from COVID-19,' said Stephane Bancel, Chief Executive Officer of Moderna. 'COVID-19 remains a serious public health threat, with more than 47,000 Americans dying from the virus last year alone. We appreciate the FDA's timely review and thank the entire Moderna team for their hard work and continued commitment to public health.' Confident Investing Starts Here:
CNBC
5 hours ago
- CNBC
FDA approves Moderna's new lower-dose Covid-19 vaccine
The U.S. approved a new Covid-19 vaccine made by Moderna late Friday but with limits on who can use it — not a replacement for the company's existing shot, but a second option. The new vaccine, mNexspike, is a step toward next-generation coronavirus vaccines. It's made in a way that allows for a lower dose — a fifth of the dose of its current Covid-19 vaccine, Spikevax — by refining its immune target. The approval "adds an important new tool to help protect people at high risk of severe disease from Covid-19," Stephane Bancel, Moderna's CEO, said in a statement Saturday. The Food and Drug Administration approved the new vaccine for use in all adults 65 and older, and for people age 12 to 64 who have a least one health condition that puts them at increased risk from the coronavirus. That's the same limit that the FDA set in licensing another Covid-19 vaccine option from competitor Novavax. Those restrictions are a departure from how the U.S. has handled Covid-19 vaccines until now, reflecting skepticism about vaccines from Health Secretary Robert F. Kennedy Jr. and other Trump officials. Moderna's existing vaccine doesn't face those limits and has long been used for anyone ages 6 months and older. The company said it expected to offer both options this fall. The FDA's approval was based on a study of 11,400 people age 12 and older that compared the new low-dose vaccine with Moderna's existing vaccine. It found the new vaccine was safe and was at least as effective — and more by some measures — than the original shot, the company said. The news came just days after the Trump administration canceled funding for Moderna to develop a vaccine against potential pandemic flu viruses, including the H5N1 bird flu, despite promising early study results.
Yahoo
11 hours ago
- Yahoo
Musk Fends Off Trump Questions in Tense Interview Exchange
A CBS interview with Elon Musk went off the rails after he was asked about President Donald Trump's crusade against Harvard. 'I'm wondering what your thought is on the ban on foreign students, the proposal,' Pogue said on CBS's Sunday Morning. 'I mean, you were one of those kids, right?' 'Yeah. I mean, I think we wanna stick to, you know, the subject of the day, which is, like, spaceships, as opposed to, you know, presidential policy,' Musk replied. 'Oh, okay,' Pogue replied. 'I was told anything is good, but—' 'No, well—no,' Musk said. The Trump administration announced on May 22 it was revoking Harvard University's ability to enroll foreign students, of which it has approximately 6,800. The move has since been blocked by the courts. Musk later went back on his refusal to talk politics, however, lamenting that the Department of Government Efficiency (DOGE) had become a 'whipping boy' for those opposed to his slash-and-burn cuts to federal programs. 'It's a bit unfair because, like, DOGE became the whipping boy for everything. So, if there was some cut, real or imagined, everyone would blame DOGE,' he said. Musk brought up the Trump administration—and his gripes with it—all on his own. 'And you know, it's not like I agree with everything the administration does,' he said. 'I agree with much of what the administration does. But we have differences of opinion. You know, there are things that I don't entirely agree with.' 'But it's difficult for me to bring that up in an interview because then it creates a bone of contention,' he added. 'So then, I'm a little stuck in a bind, where I'm like, well, I don't wanna, you know, speak up against the administration, but I also don't wanna take responsibility for everything this administration's doing.' Musk also remarked on Trump's 'big, beautiful' spending package that passed the House. The nonpartisan Congressional Budget Office said the package would add $3.8 trillion to the federal debt over 10 years, and Musk told CBS he was 'disappointed' to see the package's cost. 'I was disappointed to see the massive spending bill, frankly, which increases the budget deficit, doesn't decrease it, and undermines the work that the DOGE team is doing,' Musk said. 'I think a bill can be 'big' or it can be 'beautiful,' but I don't know if it could be both. My personal opinion.' Shortly after CBS released a clip of Musk's comments on the spending bill on Tuesday, Musk announced on X that he would officially leave his role as a 'special government employee.' He told CBS he would still have some involvement with the agency, but he wanted to prioritize his companies. 'DOGE is gonna continue, just as a way of life,' he said. 'I will have some participation in that, but as I've said publicly, my focus has to be on the companies at this point.'
